Cargando…
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
The SARS-CoV-2 infection is associated with pulmonary coagulopathy, which determines the deposition of fibrin in the air spaces and lung parenchyma. The resulting lung lesions compromise patient pulmonary function and increase mortality, or end in permanent lung damage for those who have recovered f...
Autores principales: | Piras, Anna Maria, Zambito, Ylenia, Lugli, Maurizio, Ferro, Baldassare, Roncucci, Paolo, Mori, Filippo, Salvatore, Alfonso, Ascione, Ester, Bellini, Marta, Crea, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761183/ https://www.ncbi.nlm.nih.gov/pubmed/33260813 http://dx.doi.org/10.3390/ph13120425 |
Ejemplares similares
-
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment
por: Vizzoni, Lucia, et al.
Publicado: (2023) -
Ultrasound emergency lateral-to-medial parasternal pericardiocentesis with high frequency probe in COVID-19: a case report
por: Ferro, Baldassare, et al.
Publicado: (2022) -
Assessment of the availability of repurposed orphan drugs in India
por: Rajueni, Khujith, et al.
Publicado: (2023) -
Repurposing the orphan drug nitisinone to control the transmission of African trypanosomiasis
por: Sterkel, Marcos, et al.
Publicado: (2021) -
Evaluation of prophylactic polyclonal anti‐D antibodies: Differences in Fc‐glycosylation in commercial products
por: Mori, Filippo, et al.
Publicado: (2021)